Industry sponsor
Clexio Biosciences Ltd.
2 registered trials on this registry. An industry sponsor is running trials with a view to approval and sale.
2
Registered trials
0
Recruiting
0
In Phase 3
2
With results posted
Working on
Substances
Trials
All 2 trials
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderNCT06340958 · Clexio Biosciences Ltd. | Completed | Phase 2 | ketamine | 23 |
| A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd. | Completed | Phase 2 | ketamine | 46 |
Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.